Stock Watch:

Brompton Funds specializes in split share corporations, delivering steady income and growth potential for investors through its expertly managed portfolios.
Explore the Blockchain Technologies ETF, offering exposure to the growing world of fintech, crypto mining, and blockchain advancements.
Bonterra Resources is strengthening its position in the Abitibi gold region through a strategic partnership and key assets, focusing on growth and exploration in this rich mining territory.
HomeBTV ShowBTV FeaturesCEO ClipsArticlesInvestor AlertsTV Ad SpotsAnalysts & ExpertsThe Agency
Request Investor Info

Pathway Health: Personalized Care to Help Improve a Patient's Quality of Life

Healthcare
February 10, 2022

One of the largest providers of chronic pain services in Canada

Pathway Health is an integrated healthcare company that provides advanced products and services to patients suffering from chronic pain and related conditions.

Additionally, Pathway is a leading partner with Canadian pharmacy companies for medical cannabis consultations. They signed agreements covering ~2,000 retail pharmacy locations nationally. With about 65,000 active patients, they are also the largest medical cannabis service provider in Canada.

For more information on Pathway Health Corp. (TSX.V: PHC) please click the request investor info button.

how to buy stocks
Investing
investing for beginners
new stocks to buy
stock market
stock picks
stocks
stocks to buy

Latest Articles

TD Q U.S. Small-Mid-Cap Equity ETF Offers an Investment Opportunity Not Seen in a Long TimeETFs
Centurion CEO Romundt Sees Generational Opportunity in Real EstateFinance
How TDAM is Redefining Technology InvestingFinance
The Canadian Securities Exchange - 20 Years a DisruptorFinance

Hot Companies

STLLR Gold
Aston Bay Holdings
KITS Eyecare Ltd.

You might also like

Healthcare
Medicus Pharma: Treatment with Non-Invasive Solutions

Medicus Pharma is transforming skin cancer care with its innovative, non-invasive chemotherapy delivery system, providing a safer and more effective alternative to traditional surgery.

Healthcare
Lexaria Bioscience: Revolutionizing GLP-1 Drug Delivery with Patented Oral Platform

Lexaria Bioscience is setting new standards in drug delivery with its patented DehydraTECH™ oral technology, optimizing absorption for GLP-1 and other high-demand drugs.

Content Broadcast on: BNN Bloomberg, CNBC, Bloomberg, FOX Business News, BIZTV, Reuters, The Globe and Mail, YouTube and more!

Discover Investment Opportunities!

Corp. Videos
Advertising
Broadcast Schedule
The Crew
About us
Contact